|
FDA Authorizes Abbott Libre Duo for Continuous Glucose and Ketone Monitoring
|
Written by: J. Smith |
Hits: 38
|
|
Awiqli, the First Once-Weekly Basal Insulin, Now Available in the US
|
Written by: J. Smith |
Hits: 99
|
|
Low Diabetes Medication Adherence Linked to Higher Cardiovascular Risk Over 10 Years
|
Written by: J. Smith |
Hits: 101
|
|
Novo Nordisk’s Ziltivekimab Fails to Reduce Cardiovascular Events in Phase 3 Trial
|
Written by: J. Smith |
Hits: 106
|
|
Retatrutide Delivers Major Weight Loss, but Real-World Success Will Depend on More Than Efficacy
|
Written by: J. Smith |
Hits: 102
|
|
Secret Shopper Study Raises Concerns About Online GLP-1 Prescribing
|
Written by: J. Smith |
Hits: 105
|
|
Novo Nordisk Evaluates Long-Acting Semaglutide Implant as Human Testing Begins
|
Written by: J. Smith |
Hits: 119
|
|
CardioMetabolic Bridge Aims to Move More Research from Lab to Treatment
|
Written by: J. Smith |
Hits: 105
|
|
Novo Nordisk Reports IT Security Incident Involving Some Clinical Trial Data
|
Written by: J. Smith |
Hits: 133
|
|
FDA Clears Dexcom Stelo as First Over-the-Counter CGM for Children
|
Written by: J. Smith |
Hits: 142
|
